ProMetic Life Sciences Inc. announced that at its 2013 annual and special meeting of shareholders, the shareholders elected Dr. Simon Best as a new board member and appointed as chairman of the board.
Liminal BioSciences Inc.
Equities
PJ2
CA53272L2021
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+22.17% | 45.01B | |
+47.19% | 40.96B | |
-5.69% | 38.62B | |
+35.36% | 32.6B | |
-8.34% | 27.49B | |
+17.27% | 27.17B | |
+48.94% | 14.61B | |
+40.70% | 12.95B | |
-2.20% | 11.36B |